Literature DB >> 3140956

Ceftriaxone and reversible cholelithiasis.

R H Meyboom, H Kuiper, A Jansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3140956      PMCID： PMC1834624          DOI： 10.1136/bmj.297.6652.858

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy.

Authors:  U B Schaad; H Tschäppeler; M J Lentze
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec
  1 in total
  4 in total

1.  Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.

Authors:  Sendia Kim; Kathleen M Gura; Mark Puder
Journal:  Pediatr Surg Int       Date:  2006-02-17       Impact factor: 1.827

2.  A symptomatic child with ceftriaxone-associated biliary pseudolithiasis.

Authors:  Naoki Kutuya; Yutaka Ozaki; Tadaharu Okazaki
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

Review 3.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

4.  Usefulness of Endoscopic Managements in Patients with Ceftriaxone-Induced Pseudolithiasis Causing Biliary Obstruction.

Authors:  Yasuhiro Doi; Yasushi Takii; Hiroyuki Ito; Norihiko Jingu; Kentaro To; Sinichiro Kimura; Koichi Kimura; Kensaku Sanefuji; Hirofumi Ikeda; Sayaka Tachibana; Takeshi Otsuka
Journal:  Case Rep Med       Date:  2017-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.